NASDAQ NMS - GLOBAL MARKET · CTOR
-1.18% · -$0.0086 · Vol 18.2K
After hours · updated 16:00:00 ET
Citius Oncology Inc

Citius Oncology Inc

Biotechnology
$0.7213
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CTOR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Citius Oncology Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Country
US

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.7300
Day high
$0.7300
Day low
$0.7013
Previous close
$0.7299
52W high
$0.7300
-1.19% from high
52W low
$0.6605
87% of range
Market cap
$67.9M
EPS
$-0.5200
Shares out
93M
Volume
18.2K
VWAP
$0.7112
Price history computed in-house
1W
+6.01%
1M
+5.02%
SMA 50 $0.6921 · above
SMA 200 $0.6921 · above
52W position 87%
Veridion warehouse edge

Warehouse intelligence for CTOR.

Veridion Score
46
0: 601: 512: 583: 104: 795: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CTOR insider activity

Citius Oncology Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for CTOR.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CTOR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CTOR in this window.
Lobbying spend

CTOR lobbying filings, year to date.

Registered lobbying filings matched to Citius Oncology Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CTOR in this window.
Latest news · CTOR
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CTOR.
Options
Sovereign unlock shows live options positioning for CTOR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.